ADDFresh
Investor UpdateFebruary 2026
01 / 13
Investor Update · February 2026

New technology.
Stronger results.
Same mission.

SAM technology delivers a step change in performance, robustness and consistency — across protein, produce and flowers.

Raising £500K for customer pilots & commercialization
96%
E. coli reduction beyond Use By Date
$160B
Global chicken market 103.2MT annually
£160M
ADDFresh revenue opportunity (2 partners)
SAM
New technology platform Step change in efficacy
ADDFresh
Fresh and nutritious for longer.
Progress Report

Update since June 2025

Significant challenges navigated. Technology breakthrough achieved. Strategy validated and ready for next phase.

Challenge

Financial Pressures

Financial constraints delayed the project and testing. The team was reduced to bring the burn rate under control and preserve capital.

Response

Lean Operations

Restructured to a lean model with prime focus on generating repeatable, commercially compelling results.

Breakthrough

SAM Technology

Innovative new SAM technology platform shows a significant step change in performance improvement. Delivers greater robustness and consistency than any previous formulation.

Strategy

Commercial Focus

Previously developed business strategy remains fully relevant. Focus on chicken and fish — high-value categories with major microbial contamination issues and a highly consolidated market structure.

→

Key takeaway: Despite the delay, the technology has leapfrogged forward. SAM represents a fundamentally better platform — and the commercial partnerships (Avara, Keohane) remain in place, awaiting positive confirmatory data to proceed to the next stage.

Trial Results · Chicken

Chicken fillet shelf-life trial

Independent microbial growth assessment — ADDFresh vs unprotected benchmark. Clear and consistent reduction in microbial colony growth post Use By Date.

Key Findings

AssayControlADDFreshReductionRating
E. coli484 CFU/g18 CFU/g▼ 96%Exceptional
Enterobacteriaceae262,20097,600▼ 63%Strong
Aerobic Colony71.6M46.0M▼ 36%Positive
Pseudomonas1.55M733,800▼ 53%Promising
All values at UBD+2 (2 days beyond Use By Date). Independent lab testing.

E. coli Suppression

UBD+2
!

E. coli is the primary pathogen regulators and retailers track. 96% suppression beyond UBD is exactly what the industry needs to reduce waste and protect consumers.

Chicken trial 1
Chicken trial 2
Chicken trial 3
Trial Results · Detailed

Consistent shelf-life performance

After Use By Date, ADDFresh consistently outperforms unprotected samples across all microbial species tested. New SAM technology indicates a step change in robustness.

Enterobacteriaceae

Beta +ve E. Coli

Pseudomonas spp

→

Tests conducted in 2026 have indicated consistent and robust shelf-life extension through reduction in growth of harmful spoilage organisms. The new SAM technology represents a step change in both robustness and consistency compared to earlier formulations.

Cross-Category Evidence

Effects across living and dead foodstuffs

SAM technology works on fundamentally different biological systems — from protein spoilage to fruit ripening to flower wilting.

Processed Poultry
Primary Target

Processed Poultry

96% E. coli reduction. Consistent suppression of Enterobacteriaceae, Pseudomonas and aerobic colony counts beyond Use By Date.

96%E. coli reduction at UBD+2
Tropical & Citrus Fruit
Produce

Tropical & Citrus Fruit

Pineapple rot retarded over 2 months at room temperature. Citrus freshness enhanced over 2 months. Dramatic visual evidence of efficacy.

2+ moRot retardation at room temp
Cut Flowers
Flowers

Cut Flowers

40% reduction in water consumption during 2-week shelf-life extension trial. Visible freshness advantage in treated vs untreated roses.

40%Less water consumption
→

Significance: Effects observed in both "living" fruit (where ripening is slowed) and "dead" protein foodstuffs (where microbial growth is suppressed) demonstrate that the technology addresses fundamental biological decay processes — not just a single mechanism.

Flower trial 1
Flower trial 2
Additional Trial Data

Soft fruit & Botrytis control

Independent trials on raspberries and tomatoes confirm broad-spectrum efficacy against fungal decay — a critical issue for the £15B+ berry and soft fruit waste market.

Raspberry Trial — Day 9 Assessment

Proven
10 punnets per treatment type (300+ raspberries). Tested at Chichester Farms at 12°C. BM = Benchmark, LAB = ADDFresh labels.
80%
Less white cells (druplets) than benchmark
60%
Less fungal growth than benchmark
75%
Less spoilage than benchmark

Botrytis Control — Tomato Trial

Significant Botrytis (grey mould) control demonstrated. Benchmark showed first fungus visual at Day 2 in cut slit. ADDFresh-treated samples remained clean through Day 8, with fungal growth only appearing after deliberate re-inoculation.

Berry trial 1
Berry trial 2
Berry trial 3
Market Opportunity

A £60 billion waste crisis

SAM technology targets the fundamental biology of decay across three massive global verticals. Commercial chicken represents the fastest route to revenue.

$160B
Global chicken market value
103.2MT annually · 5.84% CAGR
$1T
Annual cost of food waste globally
FAO estimate
20%
Of all meat produced is lost or wasted
Highest losses in distribution & storage
SDG 12.3
UN target: halve food waste by 2030
Regulatory tailwind
Primary Target

Poultry

~140M tonnes/year. Pathogens (E. coli, Campylobacter) and spoilage. Highly consolidated market enables rapid penetration.
£39Bvalue at risk from waste
High Margin

Cut Flowers

£30B market value. Botrytis (grey mould) and rapid wilting. Partners: Mester Grønn & MM Flowers.
£5Bvalue at risk from waste
Volume King

Berries & Fruit

45% global waste rate. Fungal decay in berries and tropicals. Partners: Dole, Bama.
£15B+value at risk from waste
Commercial Pipeline

Partnerships in place

Commercial discussions and partnerships ready to proceed — awaiting positive confirmatory data from next round of testing.

CategoryPartnerCountryYear 1 / £M
ChickenAvara & Pilgrim's
Cargill / JBS owned		UK£1.7M
FlowersMester Grønn & MM FlowersUK, NO£0.8M
FishKeohaneUK£0.4M
TropicalsDoleUS/EU£2.1M
Soft FruitBamaNO£0.1M
Total Year 1 Revenue Potential£5.1M
Avara Foods
Pilgrim's
Dole

UK Poultry — Size of Prize

Quantifying the immediate revenue potential with just two key partners:
Pilgrim's UK
JBS owned · ~5M birds/week
£5.2M
ARR potential
Avara Foods
Cargill · ~4M birds/week
£4.2M
ARR potential
£9.4M+
Combined ARR at £10/tonne license fee
£

At £10/tonne cost, partners only need to save 0.25% of product from waste to break even. With chicken retail value at ~£4,000/tonne, any savings above 0.25% is pure margin protection.

Competitive Positioning

Why ADDFresh wins

Current preservation methods require expensive infrastructure, alter packaging, or use chemicals. ADDFresh delivers superior efficacy with zero additives and minimal integration cost.

DimensionADDFresh BiofieldRefrigerationMAPChemical Preservatives
Pathogen Suppression●●●
96% E. coli reduction		●●●
Slows growth only		●●●
Limited control		●●●
High efficacy
Zero Additives●●●
Pure EM fields		●●●
Physical only		●●●
Gas only		●●●
Substances contact food
Infrastructure●●●
None — label only		●●●
Expensive cold chain		●●●
Special packaging		●●●
Application equipment
Operating Cost●●●
£0.05–0.08/pkg		●●●
High energy costs		●●●
£0.15–0.30 premium		●●●
£0.03–0.06/kg
Regulatory●●●
Packaging (EU cleared)		●●●
No approval needed		●●●
Packaging approval		●●●
18-36 month approval
⚡

Competitive moat: ADDFresh uniquely combines superior pathogen suppression with zero infrastructure requirements and no additives. Only biofield technology delivers all three: efficacy + simplicity + clean label. Energy costs make refrigeration increasingly expensive — electromagnetic preservation is a paradigm shift.

Roadmap

Three phases to commercial scale

Confirmatory next-round testing will allow progression to commercial partner testing with Avara and Keohane.

PHASE 01
Confirmatory Testing
Q1–Q2 2026
  • →Clear costs of first and second round testing
  • →Replicate studies with commercial partners
  • →Expand to pork, mince, and fish categories
  • →File IP protection in key markets
  • →Regulatory pre-submission consultations
PHASE 02
Partner Trials
Q2–Q3 2026
  • →Live pilot with Avara and Keohane
  • →Commercial-scale production trials
  • →Retail partner engagement & shelf trials
  • →Sensory panel & consumer testing
  • →Regulatory submissions for EU & UK
PHASE 03
Commercial Launch
Q3–Q4 2026
  • →Full commercial supply agreements
  • →Multi-category deployment
  • →International market expansion
  • →Series A to fund scale manufacturing
  • →Build-out of technical sales team
→

Immediate need: UK requirement to clear costs of first and second round testing and associated expenses is £10k. This unlocks the pathway to commercial partner testing and the full roadmap above.

Execution Plan

Key milestones next 12-18 months

Clear, time-bound deliverables from pilot execution to commercial revenue. Each milestone de-risks the business and unlocks the next phase of growth.

Months 1-3

Foundation & First Pilots

  • ✓Clear existing liabilities (£50k) and complete Malta relocation (£30k)
  • ✓Keep lean 3-person core team
  • ✓Launch pilot #1 with Avara Foods (UK poultry, 1-2 month trial)
  • ✓Initiate pilot #2 with Keohane Seafood (Irish fish processing)
  • ✓Launch pilots #3-4 across new categories (tropicals with Dole, flowers with Mester Grønn (NO) and MM Flowers (UK))
  • ✓Establish testing protocols and KPI tracking systems
Months 4-9

Scale Pilots & Expand Team

  • ✓Add 2 headcount: Sales/BD and R&D technician (5-person team)
  • ✓Secure first commercial contract (£500k-1M ARR target)
  • ✓Refine SAM formulation based on pilot feedback
Months 10-18

Commercial Deployment & Revenue

  • ✓Deploy commercial solution with anchor partner (Avara or Pilgrim's)
  • ✓Achieve £1M+ ARR from initial deployments
  • ✓Sign 2-3 additional commercial contracts
  • ✓Prepare Series A materials (£3-5M raise for scaling)
  • ✓Establish manufacturing/distribution partnerships
5+
Pilots Completed
Month 6-9
First Revenue
£1M+
ARR Target

Pilot Execution Timeline

Pilot Program
M1
M2
M3
M4
M5
M6
M7
M8
M9
M10
M11
M12
M13
M14
M15
M16
M17
M18
Avara Foods (Poultry)
UK
2mo
Keohane Seafood (Fish)
IE
2mo
Dole (Tropical Fruit)
Global
2mo
Mester Grønn (Flowers)
NO
2mo
MM Flowers (Flowers)
UK
2mo
Commercial Rollout
Scale
14mo
Timeline Key:
Foundation (M1-3)
Scale (M4-9)
Commercial (M10-18)
The Ask

£500K to commercial breakthrough

We have irrefutable proof the technology works and is stable. Now we need to execute customer pilots and drive commercialization.

Seed Extension Round
£500K
6-9 month runway to commercial breakthrough through customer pilots
Key Milestones Funded
  • →Execute customer pilots across 3-5 partners (1-2 months each)
  • →Build commercial evidence and case studies
  • →Accelerate pilot velocity as traction builds
  • →Sign first commercial contracts
  • →Position for growth capital raise
Use of Funds
  • 40%Customer Pilots (£200K) — Execute 3-5 commercial pilots with partners (1-2 months each), build case studies and evidence
  • 25%Team & Operations (£125K) — Core team (3-5 people), travel, and operational infrastructure
  • 20%Testing & Validation (£100K) — Ongoing testing, quality assurance, and technical support for pilots
  • 10%Existing Liabilities (£50K) — Clear outstanding bills and obligations
  • 5%Working Capital (£25K) — Contingency buffer for pilot adjustments
📊

Revenue Projection: Conservative model shows £2.8M Year 1 revenue (2 partners), £8.5M Year 2 (5 partners), £18.2M Year 3 (10+ partners). Gross margins of 65-70%.

💰

Path to Series A: This round positions us to raise £5-8M Series A in Q4 2026 at 3-4x valuation step-up, backed by commercial traction and multi-partner validation.

Summary

The data is in.
The market is ready.
Let's scale.

Validated Science
96% E. coli reduction. SAM technology outperforms on every metric tested. Effects confirmed across protein, fruit and flowers. These aren't projections — these are results.
Massive Market
$160B chicken market. £60B+ total addressable across three verticals. Highly consolidated market structure enables rapid penetration with just 2-3 anchor partners.
Clear Path to Revenue
£5.1M Year 1 partner pipeline. £160M revenue opportunity with just two UK poultry partners. B2B licensing model with 65-70% gross margins.
Ready for Commercialization
Partnerships in place with Avara, Pilgrim's, Keohane, Dole. Technology proven stable. Customer pilots are the final step to commercial deployment and revenue.
ADDFresh|Fresh and nutritious for longer.
Contact · [email protected]
CONFIDENTIAL · February 2026